Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease

scientific article published on 28 January 2012

Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJCARD.2011.12.105
P698PubMed publication ID22284271

P50authorKonstantinos StellosQ39374538
Eike NagelQ45907623
P2093author name stringStephan von Haehling
Wolfram Doehner
Jana Papassotiriou
Boris Bigalke
Meinrad Gawaz
Nils G Morgenthaler
Andreas Schuster
Thomas Wurster
Oliver Hartmann
P433issue1
P921main subjectcoronary artery diseaseQ844935
P304page(s)27-32
P577publication date2012-01-28
P1433published inInternational Journal of CardiologyQ2357863
P1476titleCopeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease
P478volume162

Reverse relations

cites work (P2860)
Q22252541A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction
Q33409185Clinical relevance of different biomarkers in imported plasmodium falciparum malaria in adults: a case control study
Q26859111Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable angina
Q37508425Copeptin and its potential role in diagnosis and prognosis of various diseases
Q37143797Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Q35778155Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis
Q90150814Copeptin levels in patients with coronary artery ectasia
Q35556651Copeptin testing in acute myocardial infarction: ready for routine use?
Q37716537Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
Q45743912Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes
Q87036597Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide
Q92152497Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry
Q38138969Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management
Q37306950Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study
Q64930840Serum Copeptin Levels Predict Clinical Outcomes After Successful Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.

Search more.